Provided by Tiger Trade Technology Pte. Ltd.

Global X Aging Population ETF

35.94
-0.1703-0.47%
Post-market: 35.91-0.0397-0.11%19:30 EDT
Volume:14.08K
Turnover:505.90K
Market Cap:87.35M
PE:- -
High:36.12
Open:36.12
Low:35.54
Close:36.12
52wk High:39.48
52wk Low:33.59
Shares:2.43M
Float Shares:2.43M
Volume Ratio:2.44
T/O Rate:0.58%
Dividend:0.33
Dividend Rate:0.92%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Edwards Lifesciences (EW) Receives a Buy from RBC Capital

TIPRANKS
·
Oct 03

Eli Lilly & Co (LLY) Gets a Buy from RBC Capital

TIPRANKS
·
Oct 03

AbbVie Joins US Government Pilot to Test Drug Discount Rebates

Reuters
·
Oct 03

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 03

Abbvie-from Jan 1, 2027, Covered Entities to Submit Claims to GET 340B Pricing Through Beacon on 340B-Eligible Dispenses of Imbruvica, Linzess,Vraylar

THOMSON REUTERS
·
Oct 03

Abbvie - Approved to Participate in Federal 340B Rebate Model Pilot Program

THOMSON REUTERS
·
Oct 03

Former Eli Lilly Exec Sells Wyoming Estate for Close to $39.5 Million

Dow Jones
·
Oct 03

Eli Lilly announces FDA approves additional indication for Jaypirca

TIPRANKS
·
Oct 03

Lilly Says FDA Approves Expanded First-Line Cll/sll Use for Jaypirca

Reuters
·
Oct 03

Lilly's Jaypirca (Pirtobrutinib), the First-and-Only Approved Non-Covalent Btk Inhibitor, Receives Expanded Indication from U.S. FDA for Certain Patients with Previously Untreated Cll/Sll

THOMSON REUTERS
·
Oct 03

AbbVie’s Venetoclax AML Study in Greece: What the Latest Update Means for Investors

TIPRANKS
·
Oct 03

Correction: Top Midday Decliners

MT Newswires Live
·
Oct 02

Abogen announces licensing, option agreement with Novartis

TIPRANKS
·
Oct 02

Major Drugmakers Turn to China for Licensing Deals

Reuters
·
Oct 02

Sanofi, Regeneron's Dupixent Successors Might Fall Short of Rivals

Dow Jones
·
Oct 02

Ventas (VTR) Receives a Buy from BMO Capital

TIPRANKS
·
Oct 02

Nanobiotix taps veteran biotech CFO Arnd Christ to steer next growth phase

TIPRANKS
·
Oct 02

Edwards Lifesciences Receives FDA Approval for Autus Valve, the First Surgical Pulmonary Valve for Pediatric Patients

THOMSON REUTERS
·
Oct 02

Sector Update: Healthcare

MT Newswires Live
·
Oct 02

US FDA - Approves Autus Size-Adjustable Valve for Pediatric Congenital Pulmonary Valve Disease

THOMSON REUTERS
·
Oct 02